Dosage and Duration of Methylprednisolone Therapy Affect the Occurrence of Cushing Habitus in Patients with Systemic Lupus Erythematosus | Zendy

Didi Yudha Permana | Zendy; MelisaI Barliana | Zendy; Laniyati Hamijoyo | Zendy

Open Access

Dosage and Duration of Methylprednisolone Therapy Affect the Occurrence of Cushing Habitus in Patients with Systemic Lupus Erythematosus

Author(s) -

Didi Yudha Permana,

MelisaI Barliana,

Laniyati Hamijoyo

Publication year - 2019

Publication title -

journal of pharmacy and bioallied sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.268

H-Index - 36

eISSN - 0976-4879

pISSN - 0975-7406

DOI - 10.4103/jpbs.jpbs_212_19

Subject(s) - medicine , population , diabetes mellitus , outpatient clinic , disease , systemic lupus erythematosus , plasmapheresis , rheumatology , comorbidity , pediatrics , immunology , endocrinology , environmental health , antibody

Systemic lupus erythematosus (SLE) is a multisystem disease with very diverse developments. Corticosteroid is mostly used for the treatment of SLE as antiinflammatory and immunosuppressant, but its long-term use and high dose can cause the side effects such as Cushing habitus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research